Item | All patients (n = 157)(%) | RDW-SD > 40.2 fl VS RDW-SD ≤ 40.2 fl | RDW-CV > 12.6% VS RDW-CV ≤ 12.6% | SCC = 0 VS SCC = 1 VS SCC = 2 |
---|---|---|---|---|
p | p | p | ||
Age ≥ 60 years | 70 (44.6) | 0.056 | 0.494 | 0.029 |
Male | 87 (55.4) | 0.900 | 0.977 | 0.882 |
BMI ≥ 24 kg/m2 | 94 (60.3) | 0.355 | 0.187 | 0.392 |
ASA score 3–4 | 13 (8.3) | 0.027 | 0.190 | 0.099 |
Cirrhosis | 57 (36.3) | 0.790 | 0.020 | 0.279 |
HBsAg ( +) | 34 (21.7) | 0.294 | 0.758 | 0.906 |
T3-T4 stage | 33 (21.0) | 0.768 | 0.005 | 0.008 |
Lymphnode metastasis | 42 (26.8) | 0.971 | 0.736 | 0.781 |
Tumor size ≥ 5 cm | 86 (54.8) | 0.314 | 0.873 | 0.854 |
Multiple tumors | 30 (19.1) | 0.357 | 0.213 | 0.067 |
Tumor location (Central tumor) | 78 (49.7) | 0.573 | 0.580 | 0.994 |
Tumor location (right lobe) | 77 (49.0) | 0.970 | 0.785 | 0.721 |
Poorly differentiation | 91 (58.0) | 0.089 | 0.515 | 0.275 |
Preoperative CA19-9 > 27 U/mL | 82 (52.2) | 0.333 | 0.279 | 0.374 |
Preoperative CEA > 5 ng/mL | 35 (22.3) | 0.174 | 0.142 | 0.202 |
RDW-SD > 40.2 fl | 104 (66.2) | – |  < 0.001 | – |
RDW-CV > 12.6% | 63 (40.1) |  < 0.001 | – | – |
SCC = 0 | 46 (29.3) | – | – | – |
SCC = 1 | 55 (35.0) | – | – | – |
SCC = 2 | 56 (35.7) | – | – | – |
ALB ≥ 40 g/L | 124 (79.0) | 0.375 | 0.133 | 0.283 |
TBIL > 21 umol/L | 18 (11.5) | 0.968 | 0.015 | 0.169 |
AST > 40 U/L | 15 (9.6) | 0.591 | 0.587 | 0.179 |
ALT > 50U/L | 14 (8.9) | 0.053 | 0.724 | 0.024 |
Operation time ≥ 230 min | 79 (50.3) | 0.027 | 0.896 | 0.052 |
Blood loss ≥ 300 ml | 77 (49.0) | 0.921 | 0.297 | 0.827 |
Major liver resection | 113 (72.0) | 0.667 | 0.548 | 0.812 |
Post-operative complications | 92 (58.6) | 0.164 | 0.720 | 0.353 |
Preoperative therapy | 10 (6.4) | 0.101 | 0.008 | 0.010 |
Adjuvant therapy | 66 (42.0) | 0.924 | 0.407 | 0.105 |